Standardized Testing, Moves to Oral Therapy, and Cost Challenges Get Attention

AJMC April 14, 2025
Pearl Steinzor

Key Takeaways

Precision medicine is advancing treatment in multiple myeloma, lung cancer, and CLL, with a focus on personalized therapies and molecular testing.
CD38 monoclonal antibodies, bispecific antibodies, and CAR T-cell therapies are pivotal in multiple myeloma management, offering deep responses and manageable toxicities.
Comprehensive molecular testing and targeted therapies are essential in lung cancer, with biomarkers like EGFR, ALK, and KRAS guiding treatment decisions.
CLL treatment is moving towards personalized oral therapies, addressing challenges like Richter transformation and financial toxicity with emerging treatments.
Medically integrated pharmacies enhance patient care by improving prescription accuracy, monitoring real-world outcomes, and adapting protocols based on patient experiences.

Coverage from the Tampa Regional session of the Institute for Value-Based Medicine.

Precision medicine...

Today's Sponsors